FIM
EDIT icon

Fernwood Investment Management’s Editas Medicine EDIT Stock Holding History

Fernwood Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-726
Closed -$5.39K – 331
2024
Q1 		$5.39K Buy
+726
New +$6.03K ﹤0.01% 630

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Fernwood Investment Management's EDIT Position: Q2 2024 in Review

Fernwood Investment Management sold out of Editas Medicine (EDIT) in Q2 2024, closing a stake of 726 shares — an estimated $5.39K sold.

Fernwood Investment Management first reported a position in EDIT in Q1 2024 and held it in 1 quarter. The position peaked at $5.39K in Q1 2024. 235 funds tracked by Wall St. Rank hold EDIT as of Q2 2024.

  • Fernwood Investment Management reported no remaining Editas Medicine position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 726 Editas Medicine shares in Q2 2024, an estimated $5.39K.
  • Fernwood Investment Management first reported a position in Editas Medicine in Q1 2024 and held it in 1 quarter.
  • Fernwood Investment Management's Editas Medicine position peaked at $5.39K in Q1 2024.
  • 235 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.